Two PCI Guidance Strategies on Par for Intermediate Coronary Stenosis
FLAVOUR trial weighs in on FFR versus IVUS
Stay updated with breaking news from Roxana Mehran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FLAVOUR trial weighs in on FFR versus IVUS
No differences in mortality, hospitalization between monitored patients and control patients
Three-fourths of patients had at least a two-grade reduction in tricuspid regurgitation, and 88% were alive 1 year after treatment with the experimental device.
Sousa is heralded as a giant in the field of interventional cardiology, a man who led the world in innovative technologies and was the first to perform procedures now taken for granted.
The cardiovascular implications for COVID-19 infections and vaccines dominated once again, with heart failure a close second.